Search results:
Search results from www.aesgp.eu
| Ingredient | ATC Level 1 | ATC Level 2 | Year Of Switch | Country | Status | Additional Information |
|---|---|---|---|---|---|---|
| Fenoprofen | N Nervous system. Nervous system | N02. Analgesics | 2022 | France | OTC | Oral use, solid forms Limit dose per unit dose (300 mg); Maximum quantity of substance released to the public (6 g); Maximum processing time (5 days) |
| Estradiol (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G03. Sex hormones and modulators of the genital system | — | France | Rx | — |
| Levodropropizine | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | France | N.R. | — |
| Bilastine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | France | Rx | — |
| lidocaine / prilocaine | N Nervous system. Nervous system | N01. Anesthetics | 2020 | France | OTC | Lidocaine/prilocaine 150 mg/ml + 50 mg/ml cutaneous spray, solution was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 27 August 2020. It is indicated for the treatment of primary premature ejaculation in adult men. |
| lidocaine / prilocaine | N Nervous system. Nervous system | N01. Anesthetics | 2020 | France | OTC | Lidocaine/prilocaine 150 mg/ml + 50 mg/ml cutaneous spray, solution was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 27 August 2020. It is indicated for the treatment of primary premature ejaculation in adult men. |
| Pholcodine | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | France | N.R. | ANSM has suspended all marketing authorisations for pholcodine-based cough syrups as of 8 September 2022. |
| Butamirate citrate | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | France | N.R. | Not registered or not marketed. |
| Atovaquone/Proguanil | P Antiparasitic products, insecticides and repellents. Antiparasitic products, insecticides and repellents | P01. Antiprotozoals | — | France | — | No information. |
| Sildenafil | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | France | Rx | — |
| Aciclovir (systemic use) | J Antiinfectives for systemic use. Antiinfectives for systemic use | J05. Antivirals for systemic use | — | France | Rx | — |
| Adapalene | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | France | Rx | — |
| Dexketoprofen | M Musculo-skeletal system. Musculo-skeletal system | M01. Antiinflammatory and antirheumatic products | — | France | Rx | Back-switched in July 2015. |
| Valaciclovir | J Antiinfectives for systemic use. Antiinfectives for systemic use | J05. Antivirals for systemic use | — | France | Rx | — |
| Econazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | — | France | OTC | — |
| Fusafungine | R Respiratory system. Respiratory system | R02. Throat preparations | — | France | N.R. | Not registered or not marketed. Withdrawn from the market in 2005. |
| Ulipristal acetate | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G03. Sex hormones and modulators of the genital system | 2015 | France | OTC | Ulipristal acetate 30mg was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 7 January 2015. It is indicated for emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure. |
| Oxitriptan | N Nervous system. Nervous system | N06. Psychoanaleptics | — | France | Rx | — |
| Yohimbine | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | France | Rx | — |
| Cetrimide | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | France | OTC | Also OTC under ATC code C05. Rx under ATC code N01 when in association with lidocaine. |
| Azelaic acid | D Dermatologicals. Dermatologicals | D10. Anti-acne preparations | — | France | Rx | — |
| Diosmin | C Cardiovascular system. Cardiovascular system | C05. Vasoprotectives | — | France | OTC | Indicated in haemorrhoidal crises and venous insufficiency. |
| Metronidazole | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | France | Rx | — |
| Desloratadine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | 2020 | France | OTC | Desloratadine 5 mg film-coated tablets was switched to non-prescription status via the centralised procedure in the entire European Union through a European Commission Decision dated 24 November 2020. It is indicated indicated in adults for the relief of symptoms associated with: - allergic rhinitis - chronic idiopathic urticaria as initially diagnosed by a physician |
| Antazoline | S Sensory organs. Sensory organs | S01. Ophthalmologicals | — | France | N.R. | Not registered or not marketed. |
| Neomycin sulfate | D Dermatologicals. Dermatologicals | D06. Antibiotics and chemotherapeutics for dermatological use | — | France | Rx | — |
| Diosmectite | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | — | France | OTC | Occasional diarrhoea. |
| Alverine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A03. Drugs for functional gastrointestinal disorders | — | France | OTC | OTC only in combination. |
| Chlorhexidine | A Alimentary tract and metabolism. Alimentary tract and metabolism | A01. Stomatological preparations | — | France | OTC | Also OTC under ATC code D08. |
| Chloroxylenol | D Dermatologicals. Dermatologicals | D08. Antiseptics and disinfectants | — | France | OTC | Solution for cutaneous use for the antiseptic cleansing of cuts, scratches and insects bites or stings in adults and children over 1 year of age. |
| Isoconazole (vaginal) | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G01. Gynecological antiinfectives and antiseptics | — | France | OTC | 2% maximum per taking, 300mg maximum per unit, maximum 2g per pack. Reimbursable, therefore no public advertising allowed. |
| Esomeprazole | A Alimentary tract and metabolism. Alimentary tract and metabolism | A02. Drugs for acid related disorders | 2013 | France | OTC | Esomeprazole 20mg was switched to non-prescription status under the centralised procedure in the entire European Union through a European Commission Decision dated 26 August 2013. It is indicated for the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults. Recommended daily dose: one 20mg gastroresistant tablet. Maximum duration of treatment: 2 weeks. Maximum 280mg per pack. |
| Trimethoprim | J Antiinfectives for systemic use. Antiinfectives for systemic use | J01. Antibacterials for systemic use | — | France | Rx | — |
| Oxybutynin | G Genito urinary system and sex hormones. Genito urinary system and sex hormones | G04. Urologicals | — | France | Rx | — |
| Lodoxamide | S Sensory organs. Sensory organs | S01. Ophthalmologicals | — | France | OTC | Eye drops 0.1%. Indicated in eye allergy in adults and children over 4 years. Reimbursable, therefore no public advertising authorised. |
| Guaifenesin | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | France | OTC | Indicated in productive cough in adults and children over 15 years of age. |
| Erdosteine | R Respiratory system. Respiratory system | R05. Cough and cold preparations | — | France | OTC | Indicated in the treatment of chronic obstructive pulmonary disease, in addition to chest physiotherapy and antibiotics, in adults and children over 15 years of age. Given the indication, no public advertising authorised. |
| Racecadotril | A Alimentary tract and metabolism. Alimentary tract and metabolism | A07. Antidiarrheals, intestinal antiinflammatory/antiinfective agents | 2008 | France | OTC | Occasional diarrhea in adults. 100mg maximum per unit, maximum 1g per pack. |
| Strontium chloride (toothpaste) | Non-classified -. - | n. a. | — | France | N.R. | — |
| Potassium nitrate (toothpaste) | Non-classified -. - | n. a. | — | France | N.R. | Not registered or not marketed. Cosmetic. |
| Decaline | Non-classified -. - | n. a. | — | France | N.R. | Not registered or not marketed. |
| Bronopol | Non-classified -. - | n. a. | — | France | N.R. | Not registered or not marketed. |
| Polymyxin B (topical) | S Sensory organs. Sensory organs | S03. Ophthalmological and otological preparations | — | France | Rx | — |
| Chloramphenicol | S Sensory organs. Sensory organs | S03. Ophthalmological and otological preparations | — | France | Rx | No product currently marketed. |
| Sulfacetamide (topical) | S Sensory organs. Sensory organs | S01. Ophthalmologicals | — | France | N.R. | Not registered or not marketed. |
| Trip(r)olidine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | France | OTC | Used in combination with pseudoephedrine and paracetamol during cold in adults and children over 15 years. |
| Tripelennamine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | France | N.R. | Not registered or not marketed. |
| Promethazine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | France | OTC | Used to relieve dry cough, especially at night, in adults and children over 2 years. |
| Oxatomide | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | France | Rx | No product currently marketed. |
| Mequitazine | R Respiratory system. Respiratory system | R06. Antihistamines for systemic use | — | France | Rx | Back-switched in 2011. |
- Page 1 of 6
- Next
- 50 of 269 ingredients